Navigation Links
Quincy Bioscience Receives Patent for Jellyfish Protein Aequorin
Date:7/7/2010

Quincy Bioscience, a research-based biotechnology company, announced the issuance of United States patent No.7,671,015. The patent covers the use of aequorin-containing compounds for the purpose of preventing and alleviating symptoms and disorders related to calcium imbalance which include Alzheimer's disease.

Madison, Wis (Vocus) July 7, 2010 -- Quincy Bioscience, a research-based biotechnology company, announced the issuance of United States patent No.7,671,015. The patent covers the use of aequorin-containing compounds for the purpose of preventing and alleviating symptoms and disorders related to calcium imbalance.

“Quincy Bioscience continues to strengthen its position in developing this novel calcium-binding protein as a platform technology,” said Mark Underwood, president of Quincy Bioscience. “The neuron’s ability to manage calcium and maintain homeostasis is fundamental to proper function. Research has proven the cell’s inability to regulate calcium is a key pathophysiological component in many different brain disorders, including Alzheimer’s disease. Based on our ongoing research of aequorin in various health conditions and what we know about the role of calcium in the body, we expect aequorin to be a vital protein in many aspects of healthy aging.”

Aequorin, which comes from a species of jellyfish called Aequorea victoria, is a calcium-binding protein. In humans calcium-binding proteins are utilized to maintain calcium balance which is critical to proper cell function. Aequorin has proven to be neuroprotective in pre-clinical studies performed at the University of Wisconsin-Milwaukee and has shown to be effective at improving aspects of cognition such as spatial working memory and executive functi
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Quincy Bioscience Announces Encouraging Preliminary Results of Randomized, Double-Blind, Placebo-Controlled Memory Study
2. Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
3. Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
4. Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service
5. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
6. Martek Biosciences and the National Center for Creative Aging Introduce New Brain Health Awareness Campaign, "Beautiful Minds: Finding Your Lifelong Potential"
7. Exalenz Bioscience Expands Market Coverage for the BreathID Breath Test System
8. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
9. Southridge LLC Provides Equity Capital Through Private Agreement with PuraMed Bioscience
10. Childrens Hospital Los Angeles oncologist receives $50,000 Hyundai Scholar Award
11. Stamen Medical Systems Receives Medicare Re-Accreditation and The Exemplary Provider Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quincy Bioscience Receives Patent for Jellyfish Protein Aequorin
(Date:6/3/2015)... Johnson & Johnson and its Janssen Pharmaceuticals ... a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) filed by the ... to market the antipsychotic drug. Court records filed ... Attorney General moved to dismiss the case on May ... amounts to just a fraction of the $1.2 billion ...
(Date:6/3/2015)... The National Resident Matching Program Board ... M.D., Dean of Medical Education at the University of California, ... July 1. , “It is an honor to ... Program,” said Dr. Savoia. “NRMP’s goal is to provide ... with training programs, and I welcome the opportunity to guide ...
(Date:6/3/2015)... On the heels of a report predicting ... 2020 ( click here to review news coverage about ... Baltimore has the talent to become a world-leading center ... and other biological data are collected and analyzed to help ... all the elements of a perfect storm for bioinformatics leadership,” ...
(Date:6/3/2015)... Horizon Blue Cross Blue Shield of New Jersey has ... nation’s top employers for diverse managers and women. The ... of Best Places for Diverse Managers and Women to Work ... This is the sixth consecutive year that Horizon BCBSNJ ... workplace policies and programs. , Companies are selected based on ...
(Date:6/3/2015)... June 03, 2015 VeoMed and ... expand online and mobile access to premier Continuing ... Maintenance of Certification (MOC) activities. ... innovative courses to Decker’s extensive lists of physicians, ... purchasing access to VeoMed’s premier online and live-streamed ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2
... The way locusts react to stress may provide ... and how to reduce their painful effects, says ... student Corinne Rodgers, Dr. Robertson is using insect models ... stress is induced through high temperatures and oxygen deprivation. ...
... success of the first three years of the American ... Physicians Foundation (ACPF) Diabetes Initiative, the program has received ... initiative for an additional two years through December 2009. ... our efforts confirm that optimal diabetes care requires a ...
... Capital Management, the,owner, together with its affiliates, of nearly ... Inc. (Nasdaq: VSTA ), announced today,that it had ... belief that the offer by Odyssey Healthcare, Inc. (Nasdaq: ... is wholly inadequate. Accipiter,Capital Management and its affiliates do ...
... Merit Medical,Systems, Inc. (Nasdaq: MMSI ), a ... in cardiology and radiology,procedures, announced today that the Company ... year ended December 31, 2007, after the,close of the ... will hold its investor conference call on the same ...
... Lotus Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) ("Lotus" ... People,s Republic of China ("PRC"), today,announced that ... owned,subsidiary of Lotus, has implemented cost saving ... costs by approximately 50%., The environmentally-friendly ...
... Hybrid electric vehicles that run on both conventional ... than a stop gap until more sustainable technology ... in the Inderscience publication International Journal of Automotive ... of HEVs might even slow development of more ...
Cached Medicine News:Health News:Comatose locusts may help relieve migraines 2Health News:Team-based approach improves diabetes care 2Health News:Team-based approach improves diabetes care 3Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 2Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 3Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 4Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 5Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 6Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 2Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 3Health News:Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies 2Health News:The trouble with hybrids 2
(Date:6/3/2015)... , June 02, 2015 Research and ... of the "Global Neurodegenerative Diseases Market 2015-2019" ... global neurodegenerative diseases market to grow at a ... This report covers the present scenario and ... market for the period 2015-2019. To calculate the ...
(Date:6/3/2015)... PillPack, the pharmacy that simplifies medication management, today announced ... led by CRV with participation from Accel Partners, Atlas ... be used to fuel growth, accelerate the hiring of ... markets. "In the last two years, we,ve ... folks absolutely love," says TJ Parker, PharmD, CEO of ...
(Date:6/3/2015)... Calif. , June 3, 2015  Armetheon, ... molecule drugs for cardiovascular diseases, today announced that ... been appointed Chief Executive Officer, effective immediately. Dr. ... in global, high-growth enterprises, with a successful track ... of human health. With expertise that includes the ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... Flextend lead is a ... with an extendable/retractable active-fixation ... design offers various lead ... implantation in the atrium ...
... leads are implantable bipolar extendable/retractable screw-in ... either the atrium or the ventricle. ... be extended or retracted by turning ... contains an anti-chattering mechanism for steady ...
Used with permanent pacing leads....
... Tupos LA, the only ICD system in ... the first implant for the treatment of ... a lasting improvement of their hemodynamics and ... LA uses biatrial stimulation to effectively suppress ...
Medicine Products: